News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
103,294 Results
Type
Article (6128)
Company Profile (10)
Press Release (97156)
Section
Business (36228)
Career Advice (320)
Deals (4661)
Drug Delivery (6)
Drug Development (14608)
Employer Resources (13)
FDA (2526)
Job Trends (2339)
News (57652)
Policy (3934)
Tag
Academia (604)
Africa (104)
Alliances (8904)
Alzheimer's disease (270)
Approvals (2519)
Arizona (25)
Artificial intelligence (16)
Asia (6013)
Australia (965)
Bankruptcy (47)
Best Places to Work (2054)
C2C Services and Suppliers (8679)
California (500)
Canada (172)
Cancer (128)
Career advice (226)
Cell therapy (18)
China (29)
Clinical research (12029)
Collaboration (47)
Colorado (19)
Connecticut (18)
COVID-19 (282)
C-suite (15)
Cystic fibrosis (24)
Data (110)
Delaware (14)
Diagnostics (922)
Drug discovery (12)
Earnings (8355)
Employer resources (12)
Europe (16193)
Events (10355)
Executive appointments (94)
FDA (2581)
Florida (44)
Funding (39)
Gene therapy (12)
Georgia (15)
GLP-1 (88)
Government (410)
Healthcare (2906)
Hotbed/Location (67831)
Illinois (31)
Indiana (25)
Infectious disease (284)
Inflammatory bowel disease (48)
Interviews (31)
IPO (1877)
Japan (19)
Job creations (334)
Job search strategy (208)
Kansas (18)
Layoffs (29)
Legal (604)
Liver cancer (12)
Lung cancer (31)
Manufacturing (12)
Maryland (41)
Massachusetts (222)
Medical device (1858)
Medtech (1859)
Mergers & acquisitions (2774)
Metabolic disorders (31)
Michigan (15)
Minnesota (25)
Multiple sclerosis (12)
Neuroscience (309)
New Jersey (125)
New York (122)
NextGen Class of 2024 (1100)
Non-profit (634)
North Carolina (93)
Northern California (212)
Obesity (17)
Ohio (32)
Opinion (22)
Patents (18)
Pennsylvania (90)
People (16782)
Phase I (3113)
Phase II (5072)
Phase III (4845)
Pipeline (37)
Postmarket research (443)
Preclinical (1054)
Press Release (12)
Radiopharmaceuticals (51)
Rare diseases (45)
Real estate (803)
Regulatory (3083)
Research institute (494)
Resumes & cover letters (100)
South America (110)
Southern California (232)
Startups (671)
Texas (42)
United States (1592)
Vaccines (47)
Washington State (42)
Date
Last 7 days (120)
Last 30 days (496)
Last 365 days (6862)
2024 (5170)
2023 (7126)
2022 (9932)
2021 (9886)
2020 (8969)
2019 (8345)
2018 (6185)
2017 (5619)
2016 (4890)
2015 (5501)
2014 (3951)
2013 (3431)
2012 (3619)
2011 (3827)
2010 (3232)
103,294 Results for "uc berkeley extension".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
UC Berkeley Launches New Molecular Therapeutics Initiative to Accelerate Drug Discovery
The University of California, Berkeley Molecular Therapeutics (MTx) division of the Molecular & Cell Biology department today announced the launch of a new initiative to accelerate drug discovery at the interface of academia and biotech.
March 14, 2024
·
5 min read
BioMidwest
DNA Nanobots Gains Exclusive License to UC Berkeley Gene Editing Technology Platform for Non-Viral Gene Delivery Solution using DNA Nanoparticles and CRISPR-Cas
DNA Nanobots, a biotechnology leader in DNA nanoparticles engineered for targeted therapeutics, announced that it completed exclusive commercial licensing of a gene editing technology from the University of California Berkeley.
June 5, 2024
·
2 min read
Biotech Bay
CatenaBio Selected to Present on its Next Generation Platform and Multi Payload Conjugates (MPC®) at the Berkeley Bio Startup Showcase @JPM
CatenaBio today announced that it has been selected by the Innovative Genomics Institute, a joint effort between UC Berkeley and UC San Francisco, to present on its proprietary CysTyr® Conjugation platform at the Berkeley Bio Startup Showcase during the J.P. Morgan Healthcare Conference in San Francisco on Tuesday, January 9, 2024.
January 4, 2024
·
4 min read
Berkeley SkyDeck Joins UC Berkeley’s Life Sciences Entrepreneurship Center to Help Launch Berkeley Faculty-Led Startups
Berkeley SkyDeck, the global hub for entrepreneurship and a leading accelerator, today announced that it has welcomed the first three companies for its new SkyDeck LSEC Bio Track: AsparaGlue, Editpep, and MZR Neurotech
May 2, 2023
·
4 min read
Biotech Beach
Immunis Welcomes UC Berkeley Professor Irina Conboy to the Scientific Advisory Board
Immunis, Inc., a private biotech company creating novel cellular secretome therapies for age and disease-related immune decline, is delighted to have Professor Irina Conboy on its Scientific Advisory Board.
September 28, 2023
·
3 min read
Business
BridgeBio Pharma Announces Founding Affiliation with Bakar Labs, Incubator at UC Berkeley’s Bakar BioEnginuity Hub
BridgeBio Pharma, Inc. (Nasdaq: BBIO), a commercial-stage biopharmaceutical company focused on genetic diseases and cancers, today announced its founding affiliation with Bakar Labs, the incubator at UC Berkeley’s Bakar BioEnginuity Hub.
July 21, 2022
·
5 min read
Press Releases
Abivax Provides Update on Ulcerative Colitis (UC) Combination Therapy Program Strategy and Announces Early Preclinical Combination Data of Obefazimod and Etrasimod in Inflammatory Bowel Disease (IBD) Mouse Model
September 26, 2024
·
7 min read
Press Releases
Lilly Canada and the pan-Canadian Pharmaceutical Alliance (pCPA) successfully complete negotiations for OMVOH® (mirikizumab) for adults with moderately to severely active ulcerative colitis (UC)
September 3, 2024
·
4 min read
Femasys Inc. Begins FemBloc Pivotal Trial Enrollment at UC Davis Medical Center, a Hub for Innovation and Groundbreaking Research in Health Care for Women
Femasys Inc. today announced that it has activated enrollment for its pivotal FemBloc® trial at University of California, Davis (“UC Davis”) Medical Center in Sacramento, California.
January 26, 2024
·
7 min read
BioMidwest
Nucleus RadioPharma Secures Series A Extension Funding with AstraZeneca Investment
Nucleus RadioPharma today announced the closing of a Series A extension round with new investor AstraZeneca (LSE/STO/Nasdaq: AZN).
June 5, 2024
·
4 min read
1 of 10,330
Next
